Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 76
Filtrar
1.
Proc Natl Acad Sci U S A ; 120(48): e2306374120, 2023 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-37983491

RESUMEN

The rather few cases of humans infected by HIV-1 N, O, or P raise the question of their incomplete adaptation to humans. We hypothesized that early postentry restrictions may be relevant for the impaired spread of these HIVs. One of the best-characterized species-specific restriction factors is TRIM5α. HIV-1 M can escape human (hu) TRIM5α restriction by binding cyclophilin A (CYPA, also known as PPIA, peptidylprolyl isomerase A) to the so-called CYPA-binding loop of its capsid protein. How non-M HIV-1s interact with huTRIM5α is ill-defined. By testing full-length reporter viruses (Δ env) of HIV-1 N, O, P, and SIVgor (simian IV of gorillas), we found that in contrast to HIV-1 M, the nonpandemic HIVs and SIVgor showed restriction by huTRIM5α. Work to identify capsid residues that mediate susceptibility to huTRIM5α revealed that residue 88 in the capsid CYPA-binding loop was important for such differences. There, HIV-1 M uses alanine to resist, while non-M HIV-1s have either valine or methionine, which avail them for huTRIM5α. Capsid residue 88 determines the sensitivity to TRIM5α in an unknown way. Molecular simulations indicated that capsid residue 88 can affect trans-to-cis isomerization patterns on the capsids of the viruses we tested. These differential CYPA usages by pandemic and nonpandemic HIV-1 suggest that the enzymatic activity of CYPA on the viral core might be important for its protective function against huTRIM5α.


Asunto(s)
Infecciones por VIH , Seropositividad para VIH , VIH-1 , Humanos , Ciclofilina A/metabolismo , Cápside/metabolismo , Proteínas de la Cápside/genética , Proteínas de la Cápside/metabolismo , VIH-1/fisiología , Proteínas de Motivos Tripartitos/genética , Proteínas de Motivos Tripartitos/metabolismo , Ubiquitina-Proteína Ligasas/genética , Ubiquitina-Proteína Ligasas/metabolismo , Infecciones por VIH/metabolismo
2.
Ann Pharm Fr ; 75(4): 285-293, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28454759

RESUMEN

OBJECTIVES: No recommendations are currently available to help the clinician with the pharmacological management of intensive care unit (ICU) patients with elevated cardiac troponin (cTn) not linked to type 1 AMI. The aim of this study was to evaluate the pattern of cardiologic medications for patients with elevated cTnI in ICU not link to type 1 AMI and their effects on in-hospital mortality. MATERIAL AND METHODS: A prospective observational cohort study conducted in two ICU units. Patients with increased plasma concentration of cTnI at admission not linked to type 1 AMI were consecutively included. RESULTS: One hundred and ninety of the 835 patients admitted (23%) had an increased plasma concentration of cTnI not related to type 1 AMI. Antiplatelet therapy (AT) and statin were prescribed in 56 (29.5%) and 50 (26.3%) of patients, respectively. Others cardiologic medications were prescribed in less than 5% of all cases and were considered as contraindicated in more than 50% of cases. Antiplatelet therapy was the only cardiologic treatment associated with reduction of in-hospital mortality following uni- and multivariate analysis. The death rate was 23% and 40% in these patients treated with and without AT, respectively (aOR=0.39 [95% CI: 0.15-0.97]). CONCLUSIONS: Statin and AT were frequently prescribed to patients with a cTnI elevation not linked to type 1 AMI. This study suggests that AT in patients with an increased plasma concentration of cTnI, not related to type 1 AMI in ICU, could reduce in-hospital mortality.


Asunto(s)
Enfermedad Crítica/mortalidad , Mortalidad Hospitalaria , Unidades de Cuidados Intensivos , Troponina I/sangre , Biomarcadores/sangre , Humanos , Infarto del Miocardio/sangre , Estudios Prospectivos
3.
Ann R Coll Surg Engl ; 99(2): e62-e64, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27791421

RESUMEN

Laparoscopic Roux-en-Y gastric bypass is one of the most commonly performed bariatric procedures and most patients are women of reproductive age. Consequently, general surgeons and obstetricians need to be aware that these patients are at risk of bariatric specific surgical complications during their pregnancy. We report a case involving a 32-year-old woman who had undergone Roux-en-Y gastric bypass surgery 2 years previously. She presented at 25 weeks of gestation with a closed loop obstruction due to a retrograde jejunojejunal intussusception that was initially misdiagnosed as acute pancreatitis.


Asunto(s)
Anastomosis en-Y de Roux/efectos adversos , Derivación Gástrica/efectos adversos , Obstrucción Intestinal , Intususcepción , Complicaciones del Embarazo , Adulto , Proteína C-Reactiva/análisis , Femenino , Humanos , Laparoscopía , Lipasa/sangre , Persona de Mediana Edad , Embarazo
4.
Eur J Clin Microbiol Infect Dis ; 35(7): 1187-93, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27142585

RESUMEN

Previous studies have shown that the high dose of gentamicin (8 mg/kg) rarely achieves the desired peak plasma concentration (Cmax) of ≥30 mg/l in patients with severe sepsis or septic shock. The aim of this study was to determine the first dose of gentamicin needed to achieve a Cmax ≥ 30 mg/l. We conducted a prospective observational cohort study in one intensive care unit. All consecutive patients hospitalized for severe sepsis or septic shock and treated with a first dose of gentamicin >6 mg/kg were evaluated. During the study period, 15 of the 57 patients (26.3 %) treated with gentamicin had a Cmax ≥ 30 mg/l. The median dose of gentamicin administered was 8.9 [7.8-9.9] mg/kg. Independent factors in the multivariate analysis associated with a Cmax ≥ 30 mg/l were higher body mass index (per kg/m(2) increment) (OR: 1.173, 95%CI: 1.015-1.356, P = 0.03) and higher first dose of gentamicin (per mg/kg increment) (OR: 2.343, 95%CI: 1.346-4.08, P = 0.003). The optimal first dose to achieve a Cmax ≥ 30 mg/l was 11 mg/kg, with a specificity and a sensitivity of 100 % and 53.3 % respectively. These results suggest that a first dose of gentamicin >11 mg/kg is needed to achieve a Cmax ≥ 30 mg/l in most patients.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Gentamicinas/administración & dosificación , Gentamicinas/farmacocinética , Sepsis/tratamiento farmacológico , Anciano , Comorbilidad , Monitoreo de Drogas , Femenino , Hospitalización , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Pronóstico , Factores de Riesgo , Sepsis/diagnóstico , Sepsis/mortalidad , Índice de Severidad de la Enfermedad , Choque Séptico/diagnóstico , Choque Séptico/tratamiento farmacológico , Resultado del Tratamiento
5.
Transpl Infect Dis ; 18(1): 22-30, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26455730

RESUMEN

BACKGROUND: Multidrug-resistant (MDR) bacteria are a growing concern worldwide. The aim of this study was to describe the epidemiology and risk factors of MDR bacteria detected in respiratory invasive samples during hospitalization in the intensive care unit (ICU) after lung transplantation (LT). METHODS: This study was based on a retrospective analysis of 176 patients hospitalized in the ICU after LT in 2006-2012. Respiratory invasive samples were performed according to a routine protocol. MDR pathogens were defined according to in vitro susceptibility tests. RESULTS: A total of 1176 bacteria were cultured. Susceptibility testing was performed on 1046 strains and 404 (39%) MDR were detected in 90 (51%) patients. Pseudomonas aeruginosa, coagulase-negative staphylococci, and Enterobacteriaceae (mainly Enterobacter species) were the most common MDR pathogens. On multivariate analysis, an ICU stay >14 days, presence of a tracheostomy, and previous exposure to broad-spectrum antibiotics were associated with MDR acquisition (odds ratio [OR] 3.7; 95% confidence interval [1.69-8.12]; OR 3.28 [1.05-10.28]; and OR 2.25 [1.17-4.34], respectively). We consistently observed an increasing emergence of resistance to several antibiotics, from week 1 to week 4 of ICU hospitalization: for ticarcillin, piperacillin-tazobactam, ceftazidime, imipenem/cilastatin, amikacin, and ciprofloxacin in P. aeruginosa; and for piperacillin-tazobactam, cefepime, and amikacin in Enterobacteriaceae. CONCLUSION: A large proportion of MDR bacteria are detected on respiratory invasive samples in LT patients, and the risk of their emergence is mainly determined by the previous exposure to broad-spectrum antibiotics and the length of ICU stay. Adequate treatment requires broad-spectrum empiric antibiotic therapy.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Bacterianas/epidemiología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Trasplante de Pulmón/efectos adversos , Infecciones Bacterianas/microbiología , Enterobacter/efectos de los fármacos , Enterobacteriaceae/efectos de los fármacos , Femenino , Hospitalización , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/epidemiología , Pseudomonas aeruginosa/efectos de los fármacos , Estudios Retrospectivos , Factores de Riesgo
6.
Transpl Infect Dis ; 17(1): 103-5, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25572932

RESUMEN

Venovenous extracorporeal membrane oxygenation (ECMO) is increasingly used in patients with respiratory failure who fail conventional treatment. Postoperative pneumonia is the most common infection after lung transplantation (40%). Imipenem is frequently used for empirical treatment of nosocomial pneumonia in the intensive care unit. Nevertheless, few data are available on the impact of ECMO on pharmacokinetics, and no data on imipenem dosing during ECMO. Currently, no guidelines exist for antibiotic dosing during ECMO support. We report the cases of 2 patients supported with venovenous ECMO for refractory acute respiratory distress syndrome following single lung transplantation for pulmonary fibrosis, treated empirically with 1 g of imipenem intravenously every 6 h. Enterobacter cloacae was isolated from the respiratory sample of Patient 1 and Klebsiella pneumoniae was isolated from the respiratory sample of Patient 2. Minimum inhibitory concentrations of the 2 isolated strains were 0.125 and 0.25 mg/L, respectively. Both patients were still alive on day 28. This is the first report, to our knowledge, of imipenem concentrations in lung transplantation patients supported with ECMO. This study confirms high variability in imipenem trough concentrations in patients on ECMO and with preserved renal function. An elevated dosing regimen (4 g/24 h) is more likely to optimize drug exposure, and therapeutic drug monitoring is recommended, where available. Population pharmacokinetic studies are indicated to develop evidence-based dosing guidelines for ECMO patients.


Asunto(s)
Antibacterianos/farmacocinética , Imipenem/farmacocinética , Trasplante de Pulmón/efectos adversos , Síndrome de Dificultad Respiratoria/terapia , Insuficiencia Respiratoria/terapia , Antibacterianos/administración & dosificación , Creatinina/sangre , Infección Hospitalaria , Oxigenación por Membrana Extracorpórea , Humanos , Imipenem/administración & dosificación , Masculino , Persona de Mediana Edad , Receptores de Trasplantes
9.
Pak J Biol Sci ; 12(18): 1282-6, 2009 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-20384283

RESUMEN

In Burkina Faso, a Western African country, reports on pneumococci carriage, resistance patterns and serotypes are inconsistent. The present study was conducted in order to evaluate these parameters. Thus 860 nasopharyngeal swabs were collected from children attending vaccination centers for pneumococci isolation, identification and serotype determination. The susceptibility to 16 antibiotics was assayed as recommended by the National Committee for Clinical Laboratory Standard (NCCLS). The results revealed that the majority of children were of 2 to 24 months age and 73.4% of children were well vaccinated. A carriage rate of 50.6% was recoded among the children. The main serotypes were: 6 (22.22%); 23 (16.67%); 7 and 9 (3.70%); 4, 11, 14, 15, 20 and 24 (1.85%). Serotypesl9, 23, 6, 7 and 18 were linked to penicillin resistance. Globally, high resistance rates to: amikacin, tetracyclin, pefloxacin, cotrimoxazol and penicillins (resistance rates greater than 25%) were recorded; however the following antibiotics remained active on the strains: rifampicin, ceftriaxone, erythromycin, spectinomycin, chloramphenicol, vancomycin, lincomycin and ciprofloxacin.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Streptococcus pneumoniae , Antibacterianos/uso terapéutico , Burkina Faso/epidemiología , Preescolar , Humanos , Lactante , Infecciones Neumocócicas/tratamiento farmacológico , Infecciones Neumocócicas/epidemiología , Infecciones Neumocócicas/microbiología , Serotipificación , Streptococcus pneumoniae/clasificación , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/patogenicidad
11.
J Dent Res ; 86(9): 888-92, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17720861

RESUMEN

Variations in the balance between cell proliferation and apoptosis could contribute to the etiology of gingival overgrowth. The aim of this study was to test the hypothesis that, in fibrotic gingival lesions, fibroblast proliferation is stimulated and apoptosis is decreased. Apoptotic index, caspase 3 expression, the proliferative index, FOXO1 expression, and histological inflammation were measured in situ. Analysis of data showed that apoptosis decreased in all forms of gingival overgrowth examined (p < 0.05), and inflammation caused a small but significant increase compared with non-inflamed tissues (p < 0.05). The greatest decrease of apoptosis occurred in the most fibrotic tissues. Cell proliferation was elevated in all forms of gingival overgrowth tested, independent of inflammation (p < 0.05). To identify potential mechanisms of transcriptional regulation of apoptosis, we assessed FOXO1 and caspase 3 expression levels and found them to correlate well with diminished apoptosis. Analysis of data suggests that increased fibroblast proliferation and a simultaneous decrease in apoptosis contribute to gingival overgrowth.


Asunto(s)
Apoptosis/fisiología , Sobrecrecimiento Gingival/patología , Anticonvulsivantes/efectos adversos , Bloqueadores de los Canales de Calcio/efectos adversos , Estudios de Casos y Controles , Caspasa 3/biosíntesis , Proliferación Celular , Ciclosporina/efectos adversos , Fibroblastos/patología , Fibromatosis Gingival/patología , Proteína Forkhead Box O1 , Factores de Transcripción Forkhead/biosíntesis , Sobrecrecimiento Gingival/inducido químicamente , Gingivitis/patología , Humanos , Inmunosupresores/efectos adversos , Etiquetado Corte-Fin in Situ , Nifedipino/efectos adversos , Fenitoína/efectos adversos , Antígeno Nuclear de Célula en Proliferación/biosíntesis
13.
Presse Med ; 26(16): 756-8, 1997 May 17.
Artículo en Francés | MEDLINE | ID: mdl-9205470

RESUMEN

BACKGROUND: Non-bacterial thrombotic endocarditis in patients with cancer can lead to ischemic stroke. Endocardial vegetations are usually small and may be missed at transthoracic echocardiography. CASE REPORT: Disseminated intravascular coagulation developed in a woman with ischemic stroke. Transthoracic echocardiography was normal. Four days later, transesophageal echocardiography revealed a large mitral vegetation suggesting non-bacterial thrombotic endocarditis. The diagnosis was confirmed at pathology which reported carcinoma of the colon. DISCUSSION: Transthoracic echocardiography is rarely contributed to the diagnosis of thrombotic endocarditis. In our patient transesophageal echocardiography grave the diagnosis before death instead of retrospectively at autopsy as usually occurs, demonstrating the value of transesophageal echocardiography for cancer patients who develop ischemic stroke.


Asunto(s)
Isquemia Encefálica/etiología , Endocarditis/complicaciones , Trombosis/complicaciones , Adenocarcinoma/complicaciones , Anciano , Isquemia Encefálica/diagnóstico por imagen , Neoplasias del Colon/complicaciones , Ecocardiografía Transesofágica , Endocarditis/diagnóstico por imagen , Femenino , Humanos , Trombosis/diagnóstico por imagen
14.
J Radiol ; 78(3): 219-22, 1997 Mar.
Artículo en Francés | MEDLINE | ID: mdl-9113149

RESUMEN

Complete disappearance of a cerebral arteriovenous malformation (AVM), 9 years after its discovery, is reported in a 45-year-old man. This unusual evolution was revealed by the onset of 3 seizures. CT scan and MR imaging eliminated any hemorrhage and carotid angiography showed the spontaneous thrombosis of the whole malformation. The evolution of the MRI signals demonstrates that seizures and the disappearance of the AVM were concomitant. It is suggested that the spontaneous thrombosis of the venous drainage caused the AVM disappearance with cerebral oedema responsible of seizures.


Asunto(s)
Malformaciones Arteriovenosas Intracraneales/fisiopatología , Embolia y Trombosis Intracraneal/etiología , Epilepsia Generalizada/etiología , Epilepsia Generalizada/fisiopatología , Humanos , Embolia y Trombosis Intracraneal/fisiopatología , Angiografía por Resonancia Magnética , Masculino , Persona de Mediana Edad , Remisión Espontánea , Factores de Tiempo , Tomografía Computarizada por Rayos X
16.
Acta Neurol Scand ; 94(5): 329-36, 1996 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8947285

RESUMEN

The occurrence of psychosis is frequent during the evolution of Parkinson's disease. The reduction of therapeutics or the use of classical neuroleptics may improve the symptoms, but usually worsens parkinsonism. Clozapine is an atypical neuroleptic with only few extrapyramidal effects, which has been proposed at low dose in this indication since 1985. A review of the literature, about more than 200 patients shows good results in approximately 90% without worsening of extrapyramidal symptoms. Some patients even noted an improvement of their motor state while treated by clozapine alone or as dopatherapy was secondarily increased. More controversial results were obtained in demented or depressed patients. Sedation is one of the most frequently encountered side-effect but rarely necessitates the withdrawal of clozapine. Even if the risk of agranulocytosis is slight, regular blood cell counts must be done.


Asunto(s)
Antiparkinsonianos/efectos adversos , Antipsicóticos/uso terapéutico , Clozapina/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Psicosis Inducidas por Sustancias/tratamiento farmacológico , Antipsicóticos/efectos adversos , Antipsicóticos/farmacología , Ensayos Clínicos como Asunto , Clozapina/efectos adversos , Clozapina/farmacología , Humanos , Psicosis Inducidas por Sustancias/etiología
17.
AORN J ; 63(4): 750, 753-8, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8660020

RESUMEN

The authors investigated music as a method to reduce ambulatory surgery patients' preoperative anxiety. They assigned 42 patients to either an experimental or a control group and compared the patients' vital signs and self-reports of anxiety, which were measured using the state portion of the State-Trait Anxiety Inventory. The study results indicate that music can be more beneficial than preoperative instruction alone in reducing ambulatory surgery patients' anxiety. Patients who listened to their choice of music before surgery in addition to receiving preoperative instruction had significantly lower heart rates than patients in the control group who received only preoperative instruction. Differences in experimental and control group patients' blood pressure measurements and respiratory rates approached significance. The authors suggest that perioperative nurses offer music as a viable option to reduce anxiety in ambulatory surgery patients who believe music is a method of relaxation.


Asunto(s)
Procedimientos Quirúrgicos Ambulatorios/psicología , Ansiedad , Música , Cuidados Preoperatorios/métodos , Adolescente , Adulto , Anciano , Ansiedad/psicología , Presión Sanguínea , Femenino , Frecuencia Cardíaca , Humanos , Masculino , Persona de Mediana Edad , Medio Oeste de Estados Unidos , Educación del Paciente como Asunto , Terapia por Relajación , Respiración
20.
Rev Neurol (Paris) ; 152(1): 32-7, 1996 Jan.
Artículo en Francés | MEDLINE | ID: mdl-8729394

RESUMEN

Latencies of lateral visually guided saccades were studied in 12 right handed patients who had unilateral ischaemic lesions involving the parietal lobe. The patients were divided into two groups according to the right or left side of the lesions. The severity of unilateral spatial neglect was assessed. In right parietal lesions, the asymmetry of latencies was related to the presence of unilateral spatial neglect and correlated with ist severity. According to the stimulus condition used, we suggest that the asymmetry of latency is explained in terms of an inability to disengage.


Asunto(s)
Lóbulo Parietal , Trastornos de la Percepción/etiología , Tiempo de Reacción , Movimientos Sacádicos , Percepción Espacial , Adulto , Anciano , Anciano de 80 o más Años , Isquemia Encefálica/complicaciones , Isquemia Encefálica/fisiopatología , Humanos , Persona de Mediana Edad , Trastornos de la Percepción/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA